![Paul da Silva Jardine](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Paul da Silva Jardine
Director/Board Member at Aethon Therapeutics, Inc.
Paul da Silva Jardine active positions
Companies | Position | Start | End |
---|---|---|---|
Aethon Therapeutics, Inc.
![]() Aethon Therapeutics, Inc. Hospital/Nursing ManagementHealth Services The company, co-founded by venture capital firm Apple Tree Partners and New York University cancer researchers Shohei Koide, Ph.D., and Benjamin G. Neel, Ph.D., unites immunotherapy and targeted therapy to expand the power and promise of both approaches for people living with cancer. Aethon Therapeutics, Inc. is based in New York, NY. Part of NYU Langone Medical Center, Aethon Therapeutics, Inc. is a company that creates neoantigens by design to transform cancer treatments into cures. The company's novel anti-drug-peptide conjugate/mhc antibodies are designed to be used in combination with targeted covalent inhibitors of ras, egfr, and other oncogenic driver mutations to mount immune attacks and selectively kill residual cancer cells, including drug-resistant "persister" cells. The company was founded by Benjamin G. Neel, Shohei Koide. The CEO is Rajesh Chopra. | Director/Board Member | - | - |
Corporate Officer/Principal | - | - |
Career history of Paul da Silva Jardine
Former positions of Paul da Silva Jardine
Companies | Position | Start | End |
---|---|---|---|
Staten Biotechnology BV
![]() Staten Biotechnology BV BiotechnologyHealth Technology Staten Biotechnology BV develops drugs for the treatment of dyslipidemia. The company was founded by Paul da Silva Jardine, Daniel Rader and Alan Tall in 2014 and is headquartered in Nijmegen, the Netherlands. | Chief Tech/Sci/R&D Officer | 2013-12-31 | - |
Founder | 2013-12-31 | - |
Statistics
International
Netherlands | 2 |
United States | 2 |
Operational
Chief Tech/Sci/R&D Officer | 1 |
Founder | 1 |
Director/Board Member | 1 |
Sectoral
Health Technology | 2 |
Health Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
Staten Biotechnology BV
![]() Staten Biotechnology BV BiotechnologyHealth Technology Staten Biotechnology BV develops drugs for the treatment of dyslipidemia. The company was founded by Paul da Silva Jardine, Daniel Rader and Alan Tall in 2014 and is headquartered in Nijmegen, the Netherlands. | Health Technology |
Aethon Therapeutics, Inc.
![]() Aethon Therapeutics, Inc. Hospital/Nursing ManagementHealth Services The company, co-founded by venture capital firm Apple Tree Partners and New York University cancer researchers Shohei Koide, Ph.D., and Benjamin G. Neel, Ph.D., unites immunotherapy and targeted therapy to expand the power and promise of both approaches for people living with cancer. Aethon Therapeutics, Inc. is based in New York, NY. Part of NYU Langone Medical Center, Aethon Therapeutics, Inc. is a company that creates neoantigens by design to transform cancer treatments into cures. The company's novel anti-drug-peptide conjugate/mhc antibodies are designed to be used in combination with targeted covalent inhibitors of ras, egfr, and other oncogenic driver mutations to mount immune attacks and selectively kill residual cancer cells, including drug-resistant "persister" cells. The company was founded by Benjamin G. Neel, Shohei Koide. The CEO is Rajesh Chopra. | Health Services |